Your browser doesn't support javascript.
loading
The effect of SGLT2 inhibitors, GLP1 agonists, and their sequential combination on cardiometabolic parameters: A randomized, prospective, intervention study.
Bechlioulis, Aris; Markozannes, Georgios; Chionidi, Ifigeneia; Liberopoulos, Evangelos; Naka, Katerina K; Ntzani, Evangelia E; Liatis, Stavros; Rizzo, Manfredi; Rizos, Evangelos C.
Afiliação
  • Bechlioulis A; 2nd Department of Cardiology, Faculty of Medicine, School of Health Sciences, University of Ioannina and University Hospital of Ioannina, Ioannina, Greece.
  • Markozannes G; Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina, Greece.
  • Chionidi I; Diabetes Outpatient Clinic, University Hospital of Ioannina, Ioannina, Greece.
  • Liberopoulos E; First Department of Propaedeutic Internal Medicine, Medical School, Laiko General Hospital, National and Kapodistrian University of Athens, Athens, Greece.
  • Naka KK; 2nd Department of Cardiology, Faculty of Medicine, School of Health Sciences, University of Ioannina and University Hospital of Ioannina, Ioannina, Greece.
  • Ntzani EE; Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina, Greece; Center for Evidence-Based Medicine, Department of Health Services, Policy and Practice, School of Public Health, Brown University, Providence, RI, USA.
  • Liatis S; First Department of Propaedeutic Internal Medicine, Medical School, Laiko General Hospital, National and Kapodistrian University of Athens, Athens, Greece.
  • Rizzo M; Department of Internal Medicine and Medical Specialties, School of Medicine, University of Palermo, Palermo, Italy.
  • Rizos EC; Department of Internal Medicine, University Hospital of Ioannina, Ioannina, Greece; School of Medicine, European University Cyprus, Nicosia, Cyprus. Electronic address: vagrizos@gmail.com.
J Diabetes Complications ; 37(4): 108436, 2023 04.
Article em En | MEDLINE | ID: mdl-36842186

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Diabetes Mellitus Tipo 2 / Rigidez Vascular / Inibidores do Transportador 2 de Sódio-Glicose / COVID-19 Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Diabetes Mellitus Tipo 2 / Rigidez Vascular / Inibidores do Transportador 2 de Sódio-Glicose / COVID-19 Idioma: En Ano de publicação: 2023 Tipo de documento: Article